Knowledge centre

Filter by

Recent posts

Vaccines – SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model
Vaccines – SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model
Read Article
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Read more
Podcast with our Chief Research Officer, Helen Horton
Read Article
The Medicine Maker: Riding the (Nucleo)Tidal Wave
The Medicine Maker: Riding the (Nucleo)Tidal Wave
Read more
Endpoints Manufacturing: Touchlight’s ‘doggyboneDNA’ looks to rewrite rules of therapeutic DNA
Endpoints Manufacturing: Touchlight’s ‘doggyboneDNA’ looks to rewrite rules of therapeutic DNA
Read more
Careers in Discovery Podcast
Careers in Discovery Podcast
Read more
Labiotech: The Manufacturing Challenge to Meet Covid-19 Vaccine Demands
Labiotech: The Manufacturing Challenge to Meet Covid-19 Vaccine Demands
Read more
Labiotech: CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution
Labiotech: CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution
Read more
The Fish Site: Aquaculture vaccine venture launched
The Fish Site: Aquaculture vaccine venture launched
Read more
Fish Focus: Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture
Fish Focus: Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture
Read more
The Spectator: How entrepreneurs have turned to face this crisis
The Spectator: How entrepreneurs have turned to face this crisis
Read more
Doggybone DNA vaccine induces similar immunological responses to plasmid DNA
Doggybone DNA vaccine induces similar immunological responses to plasmid DNA
Read more